치매 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 9.7%의 연평균 성장률로 291억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 의료비 지출 증가, 만성질환 유병률 증가, 임상시험 증가, 제약 산업 성장, 알츠하이머병 발병률 증가 등의 요인에 기인할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 과학 연구의 발전, 진단 및 치료 관리를 위한 인공지능 및 머신러닝의 활용, 신약 및 치료법 개발, 생명공학에 대한 투자 증가, 맞춤형 치료 접근법의 발전 등을 꼽을 수 있습니다.
신경 퇴행성 질환의 유병률 증가는 향후 몇 년 동안 치매 치료 시장의 성장을 촉진할 것으로 예상됩니다. 신경퇴행성 질환은 신경세포의 진행성 퇴행과 상실을 동반하여 운동, 인지, 또는 둘 다에 장애를 초래하는 질환입니다. 이러한 신경퇴행성 질환의 증가는 평균 수명의 연장이 알츠하이머병, 파킨슨병과 같은 노화 관련 질환의 위험을 높이고, 노화가 주요 요인으로 작용하고 있는 고령화 사회에 기인합니다. 신경퇴행성 질환에 대한 이해가 깊어지면 보다 정확한 진단과 표적 치료가 가능해지며, 증상에 맞는 효과적인 접근이 가능해지기 때문에 치매 치료가 강화될 수 있습니다. 예를 들어, 알츠하이머병 협회가 2024년 4월 발표한 보고서에 따르면, 65세 이상 미국인 중 약 690만 명이 알츠하이머형 치매를 앓고 있으며, 이 숫자는 2060년까지 두 배인 1,380만 명으로 증가할 것으로 예측하고 있습니다. 이에 따라 신경퇴행성 질환의 유병률 증가가 치매 치료 시장의 성장을 크게 견인할 것으로 보입니다.
치매 치료 분야의 주요 기업들은 복잡하고 다양한 시나리오를 재현하는 가상현실(VR) 훈련 프로그램 등 첨단 기술 솔루션 개발에 주력하고 있습니다. 가상 환경에서 기술을 연습하고 연마할 수 있는 기회를 제공합니다. 예를 들어, 2024년 9월 일본 오츠카제약(Otsuka Pharmaceutical Co. Ltd.)은 일본 의료 기술 기업 졸리굿(Jolly Good Inc.)과 협력하여 치매 치료에 특화된 VR 교육 프로그램인 'FACEDUO'를 발표했습니다. 의료 전문가가 감수한 이 대화형 VR 도구는 가족을 포함한 간병인이 치매 환자의 감정과 행동을 이해할 수 있도록 돕습니다. 실제 상황을 시뮬레이션함으로써 간병인은 치매 환자의 고유한 요구에 보다 효과적으로 대응할 수 있게 됩니다. 이 프로그램의 주요 목적은 간병 능력을 향상시키고, 보다 효과적인 지원을 위한 공감 능력을 기르는 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 치매 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 치매 치료 시장 : 성장률 분석
- 세계의 치매 치료 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 치매 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 치매 치료 전체 시장(TAM)
제6장 시장 세분화
- 세계의 치매 치료 시장 : 치료 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 항정신병제
- 콜린에스테라아제 억제제
- 메만틴
- 기타
- 세계의 치매 치료 시장 : 적응증별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 알츠하이머형 치매
- 혈관성 치매
- 루이소체 치매
- 전두측두엽 치매
- 파킨슨형 치매
- 기타
- 세계의 치매 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 경피 패치
- 주사제
- 세계의 치매 치료 시장 : 치매 단계별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 경도 치매
- 중등도 치매
- 중증 치매
- 세계의 치매 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 치매 치료 시장 : 항정신병제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 비정형 항정신병제
- 정형 항정신병제
- 세계의 치매 치료 시장 : 콜린에스테라아제 억제제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 도네페질
- 리바스티그민
- 갈란타민
- 세계의 치매 치료 시장 : 메만틴 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 메만틴 단독요법
- 메만틴 병용요법
- 세계의 치매 치료 시장 : 기타 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 인지 기능 향상제
- NMDA 수용체 길항제
- 식이보충제·허브보충제
- 호르몬 치료
- 줄기세포 치료
제7장 지역별·국가별 분석
- 세계의 치매 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 치매 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 치매 치료 시장 : 경쟁 구도
- 치매 치료 시장 : 기업 개요
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Biogen Inc.
- Eisai Co. Ltd.
- Merz Pharmaceuticals GmbH
- Acadia Pharmaceuticals Inc.
- Intra-Cellular Therapies Inc.
- Cerevance Inc.
- Retro Biosciences Inc.
- AviadoBio Ltd.
- MapHabit Inc.
- Neuvivo Inc.
- Harmonic Health Inc.
- Rippl Care Inc.
- Isaac Health Inc.
- EmTech Care Labs Inc.
- LifeBio Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 치매 치료 시장 2029년 : 새로운 기회를 제공하는 국가
- 치매 치료 시장 2029년 : 새로운 기회를 제공하는 부문
- 치매 치료 시장 2029년 : 성장 전략
제36장 부록
ksm
Dementia treatment involves a combination of medical, psychological, and supportive approaches aimed at managing symptoms and slowing the progression of the condition, which is characterized by memory loss, cognitive decline, and difficulty with reasoning. Early detection of dementia enables more effective intervention and facilitates the preparation of long-term care plans. Tailored treatment strategies, based on the specific type and stage of dementia, can enhance the quality of life for those affected.
The primary treatment options for dementia include antipsychotics, cholinesterase inhibitors, memantine, and others. Antipsychotic medications are prescribed to manage behavioral and psychological symptoms in dementia patients, such as aggression, agitation, and hallucinations. These medications are used to treat various forms of dementia, including Alzheimer's disease dementia, vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson's disease dementia, and others. Antipsychotics can be administered via oral tablets, transdermal patches, or injectables, and are used for managing mild, moderate, and severe stages of dementia. They are typically distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The dementia treatment market research report is one of a series of new reports from The Business Research Company that provides dementia treatment market statistics, including dementia treatment industry global market size, regional shares, competitors with a dementia treatment market share, detailed dementia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dementia treatment industry. This dementia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dementia treatment market size has grown strongly in recent years. It will grow from $18.32 billion in 2024 to $20.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to factors such as the aging population, improved diagnosis rates, greater awareness of dementia, the expansion of healthcare infrastructure, and increased government funding for dementia research and treatment.
The dementia treatment market size is expected to see strong growth in the next few years. It will grow to $29.12 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to factors such as increased healthcare expenditure, a higher prevalence of chronic diseases, more clinical trials, growth in the pharmaceutical industry, and rising rates of Alzheimer's disease. Key trends in the forecast period include advancements in scientific research, the use of artificial intelligence and machine learning for diagnosis and treatment management, the development of new drugs and therapies, increased investment in biotechnology, and progress in personalized treatment approaches.
The rising prevalence of neurodegenerative disorders is expected to drive the growth of the dementia treatment market in the coming years. Neurodegenerative disorders, which involve the progressive degeneration and loss of nerve cells, lead to impairments in movement, cognition, or both. This increase in neurodegenerative disorders is largely attributed to the aging population, as longer life expectancy raises the risk of age-related conditions such as Alzheimer's and Parkinson's disease, with age being the primary contributing factor. A deeper understanding of neurodegenerative disorders enhances dementia treatment by enabling more accurate diagnoses and targeted therapies, allowing for a more personalized and effective approach to managing symptoms. For instance, according to a report published in April 2024 by the Alzheimer's Association, approximately 6.9 million Americans aged 65 and older were affected by Alzheimer's dementia, with projections suggesting this number will double to 13.8 million by 2060. As a result, the growing prevalence of neurodegenerative disorders will significantly drive the growth of the dementia treatment market.
Leading companies in the dementia treatment sector are concentrating on developing advanced technological solutions, such as virtual reality (VR) training programs, to replicate intricate and varied scenarios. VR training programs are immersive, computer-generated experiences that provide individuals with the opportunity to practice and refine their skills in a controlled, interactive, and realistic virtual setting. For example, in September 2024, Otsuka Pharmaceutical Co. Ltd., based in Japan, collaborated with Jolly Good Inc., a medical technology company from Japan, to introduce FACEDUO, a VR training program tailored for dementia care. This interactive VR tool, overseen by medical professionals, assists caregivers, including family members, in understanding the emotions and behaviors of individuals with dementia. By simulating real-life situations, the program enables caregivers to respond more effectively to the specific needs of dementia patients. Its primary goal is to enhance caregiving abilities and foster empathy for more impactful support.
In April 2024, Rippl, a US-based provider specializing in dementia care, acquired Kinto for an undisclosed sum. This acquisition aims to expedite the development of Rippl's dementia care platform by integrating artificial intelligence (AI)-driven solutions to enhance patient care. Kinto, a US-based AI healthcare company, focuses specifically on dementia care.
Major players in the dementia treatment market are Roche Holding AG, AbbVie Inc., Sanofi S.A., Eli Lilly and Company, Amgen Inc., Biogen Inc., Eisai Co. Ltd., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Cerevance Inc., Retro Biosciences Inc., AviadoBio Ltd., MapHabit Inc., Neuvivo Inc., Harmonic Health Inc., Rippl Care Inc., Isaac Health Inc., EmTech Care Labs Inc., and LifeBio Inc.
North America was the largest region in the dementia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dementia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the dementia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dementia treatment market consists of revenues earned by entities by providing services such as medication management, cognitive therapy and stimulation, and behavioral and psychological support. The market value includes the value of related goods sold by the service provider or included within the service offering. The dementia treatment market also includes sales of memory-enhancing medications, nutritional supplements, cognitive stimulation tools, and medical alert systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dementia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dementia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dementia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dementia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Antipsychotics; Cholinesterase Inhibitors; Memantine; Other Treatment Types
- 2) By Indication: Alzheimer's Disease Dementia; Vascular Dementia; Lewy Body Dementia; Frontotemporal Dementia; Parkinson Disease Dementia; Other Indications
- 3) By Route of Administration: Oral; Transdermal Patch; Injectable
- 4) By Stage of Dementia: Mild Dementia; Moderate Dementia; Severe Dementia
- 5) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
- Subsegments:
- 1) By Antipsychotics: Atypical Antipsychotics; Typical Antipsychotics
- 2) By Cholinesterase Inhibitors: Donepezil; Rivastigmine; Galantamine
- 3) By Memantine: Memantine Monotherapy; Memantine Combination Therapy
- 4) By Other Treatment Types: Cognitive Enhancers; NMDA Receptor Antagonists; Nutritional And Herbal Supplements; Hormonal Treatments; Stem Cell Therapy
- Companies Mentioned: Roche Holding AG; AbbVie Inc.; Sanofi S.A.; Eli Lilly and Company; Amgen Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Dementia Treatment Market Characteristics
3. Dementia Treatment Market Trends And Strategies
4. Dementia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Dementia Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Dementia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Dementia Treatment Market Growth Rate Analysis
- 5.4. Global Dementia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Dementia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Dementia Treatment Total Addressable Market (TAM)
6. Dementia Treatment Market Segmentation
- 6.1. Global Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antipsychotics
- Cholinesterase Inhibitors
- Memantine
- Other Treatment Types
- 6.2. Global Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alzheimer's Disease Dementia
- Vascular Dementia
- Lewy Body Dementia
- Frontotemporal Dementia
- Parkinson Disease Dementia
- Other Indications
- 6.3. Global Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Transdermal Patch
- Injectable
- 6.4. Global Dementia Treatment Market, Segmentation By Stage of Dementia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mild Dementia
- Moderate Dementia
- Severe Dementia
- 6.5. Global Dementia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- 6.6. Global Dementia Treatment Market, Sub-Segmentation Of Antipsychotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Atypical Antipsychotics
- Typical Antipsychotics
- 6.7. Global Dementia Treatment Market, Sub-Segmentation Of Cholinesterase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Donepezil
- Rivastigmine
- Galantamine
- 6.8. Global Dementia Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Memantine Monotherapy
- Memantine Combination Therapy
- 6.9. Global Dementia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cognitive Enhancers
- NMDA Receptor Antagonists
- Nutritional And Herbal Supplements
- Hormonal Treatments
- Stem Cell Therapy
7. Dementia Treatment Market Regional And Country Analysis
- 7.1. Global Dementia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Dementia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dementia Treatment Market
- 8.1. Asia-Pacific Dementia Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dementia Treatment Market
- 9.1. China Dementia Treatment Market Overview
- 9.2. China Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dementia Treatment Market
- 10.1. India Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dementia Treatment Market
- 11.1. Japan Dementia Treatment Market Overview
- 11.2. Japan Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dementia Treatment Market
- 12.1. Australia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dementia Treatment Market
- 13.1. Indonesia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dementia Treatment Market
- 14.1. South Korea Dementia Treatment Market Overview
- 14.2. South Korea Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dementia Treatment Market
- 15.1. Western Europe Dementia Treatment Market Overview
- 15.2. Western Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dementia Treatment Market
- 16.1. UK Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dementia Treatment Market
- 17.1. Germany Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dementia Treatment Market
- 18.1. France Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dementia Treatment Market
- 19.1. Italy Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dementia Treatment Market
- 20.1. Spain Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dementia Treatment Market
- 21.1. Eastern Europe Dementia Treatment Market Overview
- 21.2. Eastern Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dementia Treatment Market
- 22.1. Russia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dementia Treatment Market
- 23.1. North America Dementia Treatment Market Overview
- 23.2. North America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dementia Treatment Market
- 24.1. USA Dementia Treatment Market Overview
- 24.2. USA Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dementia Treatment Market
- 25.1. Canada Dementia Treatment Market Overview
- 25.2. Canada Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dementia Treatment Market
- 26.1. South America Dementia Treatment Market Overview
- 26.2. South America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dementia Treatment Market
- 27.1. Brazil Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dementia Treatment Market
- 28.1. Middle East Dementia Treatment Market Overview
- 28.2. Middle East Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dementia Treatment Market
- 29.1. Africa Dementia Treatment Market Overview
- 29.2. Africa Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dementia Treatment Market Competitive Landscape And Company Profiles
- 30.1. Dementia Treatment Market Competitive Landscape
- 30.2. Dementia Treatment Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Dementia Treatment Market Other Major And Innovative Companies
- 31.1. Biogen Inc.
- 31.2. Eisai Co. Ltd.
- 31.3. Merz Pharmaceuticals GmbH
- 31.4. Acadia Pharmaceuticals Inc.
- 31.5. Intra-Cellular Therapies Inc.
- 31.6. Cerevance Inc.
- 31.7. Retro Biosciences Inc.
- 31.8. AviadoBio Ltd.
- 31.9. MapHabit Inc.
- 31.10. Neuvivo Inc.
- 31.11. Harmonic Health Inc.
- 31.12. Rippl Care Inc.
- 31.13. Isaac Health Inc.
- 31.14. EmTech Care Labs Inc.
- 31.15. LifeBio Inc.
32. Global Dementia Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dementia Treatment Market
34. Recent Developments In The Dementia Treatment Market
35. Dementia Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Dementia Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Dementia Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Dementia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
